Viridian Therapeutics, Inc. (VRDN)

28.07 +0.63 (+2.30%) USD  |  NASDAQ  |  Feb 23, 16:00
28.16 +0.09 (+0.32%) After-Hours: 04:46
More

Viridian Therapeutics Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for VRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Avantor, Inc. Upgrade
Immunovant, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade